Loading clinical trials...
Loading clinical trials...
The Effects of the Female Sex Hormones and Hormonal Contraception on Cerebral Perfusion
Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey matter, resting-state brain activity, brain connectivity and white matter diffusion) caused by the female sex hormones and hormonal contraception.
Age
18 - 25 years
Sex
FEMALE
Healthy Volunteers
Yes
Ghent University Hospital
Ghent, Belgium
Start Date
October 3, 2016
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
December 6, 2023
62
ESTIMATED participants
MRI scan
DEVICE
Physiological monitoring
DEVICE
Blood sample
BIOLOGICAL
Blood pressure measurement
DEVICE
Body temperature
DEVICE
Questionnaires
OTHER
Pregnancy test
DIAGNOSTIC_TEST
Lead Sponsor
University Ghent
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06672016